Forest Labs Inc (NYSE:FRX)
The Company and its subsidiaries develop, manufacture and sell both branded and generic forms of ethical drug products which require a physician's prescription, as well as non-prescription pharmaceutical products sold over-the-counter.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
For reference point and to allow for comments by others. As of the end of March, 2013.
ROE 0.57%
Trailing PE N/A
PB 1.82
Div yield N/A
Recs
Bullish MACD crossover on 02/20/13
Recs
Best sellers are facing patent cliff and most of other products are competing with existing effective and safe generics.
Recs
Icahn will be working from within to unlock the value that is already there.
Recs
carl icahn
Recs
Drug companies always find a way
Recs
Good firm available for less than 10x anuual R&D and a PE of 18.
Recs
Recs
Recs
Under priced.
Recs
magic formula
Recs
One word, MRSA. They have the drug to fight it.
Recs
Value Stocks Screen Multiple Ratios
Recs
Technical Indicator: LCR-20
Recs
patents that it holds
Recs
This company has carved out a profitable niche
Recs
Recs
This is the one of the the hardest stock to predict. Lexapro is the 2nd most prescribed drug in America. Government rules regarding patents mean the drug will go generic in 2012. This means FRX's major revenue stream will dry up.
In 2011 people will start selling. Until then it's do well.
With no end in sight for the recession people will continue to be depressed and doctors will prescribe anti-depressant. There is plenty of research on the relationship between recessions (or future outlooks) and depression
Recs
On 30 stocks over $50 million market cap magic formula screen
owned for the past year as part of my Magic Formula portfolio. I should be selling it this month, but it is still showing up on the Magic Formula screen. Lots of cash flow and a big cash hoard with no debt. The question is what are they going to do with all that money. There was a new share repurchase program approved by the board in May 2010 for 50 million shares, but there is not plan on when to carry that out. Earnings have been weakening the past couple of years, but I see no big reason to sell, so I will hold onto this stock for another year with my real money Magic Formula portfolio.
Recs
MFI Top 50, amazing balance sheet, $500M stock buyback program.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 71 : 1 2 3 4 Next »